Market Tracker

09/26 5:16pm ET

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

11.64
Delayed Data
As of 3:59pm ET
 -0.23 / -1.94%
Today’s Change
7.86
Today|||52-Week Range
18.85
-21.56%
Year-to-Date
No recent news for Momenta Pharmaceuticals Inc.

Today’s Trading

Previous close11.87
Today’s open11.92
Day’s range11.63 - 11.92
Volume311,147
Average volume (3 months)538,216
Market cap$842.6M
Dividend yield--
Data as of 3:59pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)+30.89%
Earnings growth (this year)+7.42%
Earnings growth (next 5 years)--
Revenue growth (last year)+71.58%
P/E ratioNM
Price/Sales10.45
Price/Book2.21

Competitors

 Today’s
change
Today’s
% change
RTRXRetrophin Inc-0.21-0.93%
AMAGAMAG Pharmaceuticals...-0.17-0.70%
BPMCBlueprint Medicines ...-1.23-4.30%
ANIPANI Pharmaceuticals ...-1.28-1.92%
Data as of 3:59pm ET, 09/26/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$89.7M
Annual profit (last year)-$83.3M
Net profit margin-92.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class II Director
Craig A. Wheeler
Chief Operating Officer
Matthew P. Ottmer
Corporate headquarters
Cambridge, Massachusetts

Forecasts